471 related articles for article (PubMed ID: 27818285)
1. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
[TBL] [Abstract][Full Text] [Related]
2. Profiling of expression of human papillomavirus-related cancer miRNAs in penile squamous cell carcinomas.
Barzon L; Cappellesso R; Peta E; Militello V; Sinigaglia A; Fassan M; Simonato F; Guzzardo V; Ventura L; Blandamura S; Gardiman M; Palù G; Fassina A
Am J Pathol; 2014 Dec; 184(12):3376-83. PubMed ID: 25455689
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
[TBL] [Abstract][Full Text] [Related]
4. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
[TBL] [Abstract][Full Text] [Related]
5. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
6. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
[TBL] [Abstract][Full Text] [Related]
7. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C
Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20.
Yao T; Lin Z
Biochim Biophys Acta; 2012 Feb; 1822(2):248-60. PubMed ID: 22001440
[TBL] [Abstract][Full Text] [Related]
11. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.
Zang B; Huang G; Wang X; Zheng S
Int J Clin Exp Pathol; 2015; 8(10):13687-94. PubMed ID: 26722596
[TBL] [Abstract][Full Text] [Related]
13. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
14. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E6 modulates the expression of host microRNAs in cervical cancer.
Ben W; Yang Y; Yuan J; Sun J; Huang M; Zhang D; Zheng J
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):364-70. PubMed ID: 26384051
[TBL] [Abstract][Full Text] [Related]
16. miR‑218 functions as a tumor suppressor gene in cervical cancer.
Liu Z; Mao L; Wang L; Zhang H; Hu X
Mol Med Rep; 2020 Jan; 21(1):209-219. PubMed ID: 31746391
[TBL] [Abstract][Full Text] [Related]
17. Unique microRNA expression profiles in cervical cancer.
Gocze K; Gombos K; Juhasz K; Kovacs K; Kajtar B; Benczik M; Gocze P; Patczai B; Arany I; Ember I
Anticancer Res; 2013 Jun; 33(6):2561-7. PubMed ID: 23749909
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
Liu X
Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
[TBL] [Abstract][Full Text] [Related]
20. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
